Wang Jianwei, Wang Shengshu, Song Yang, Huang MingJun, Cao Wenzhe, Liu Shaohua, Chen Shimin, Li Xuehang, Liu Miao, He Yao
Institute of Geriatrics, The Second Medical Center & National Clinical Research Center for Geriatrics Diseases, Beijing Key Laboratory of Research on Aging and Related Diseases, State Key Laboratory of Kidney Disease, Chinese PLA General Hospital, Beijing, 100853, People's Republic of China.
Graduate School of Chinese PLA General Hospital, Beijing, 100853, People's Republic of China.
J Multidiscip Healthc. 2023 Apr 7;16:963-970. doi: 10.2147/JMDH.S398704. eCollection 2023.
To investigate the preventive effect of distal perfusion catheters (DPCs) on vascular complications in patients undergoing venous artery extracorporeal membrane oxygenation (VA-ECMO).
Patients who underwent VA-ECMO through a femoral approach in our hospital were included in this study, and they were divided into two groups according to their use of DPC. Clinical indicators were compared between the two groups, including the ECMO running time, intensive care unit (ICU) time, length of hospital stay, ECMO auxiliary results, the incidence of limb ischemia and vascular complications.
In total, 250 patients were included in this study, including the DPC group (age: 48 [32-62] years old, 58.4% male, n = 125) and the non-DPC group (age: 51 [36-63] years old, 65.6% male, n = 125). The DPC group was less likely to have limb complications than the non-DPC group (6.4% vs 17.6%, = 0.006), mainly resulting from distal ischemia (4.0% vs 15.2%, = 0.003) and necrosis (1.6% vs 9.6%, = 0.006). The ECMO duration had a median of 92.3 (75.7-109) h in the DPC group and 71.2 (59.4-82.8) h in the DPC group, with a difference close to the statistical threshold ( = 0.054). There was no significant difference in ICU time or length of hospital stay between the two groups. The multivariate analysis showed that the DPC implantation was negatively associated with limb complications (odds ratio: 0.265, 95% confidence interval: 0.107-0.657, = 0.004) after adjustment for confounding factors.
Distal perfusion catheter placement might be associated with a decreased risk of vascular complications and limb ischemia in patients undergoing femoral VA-ECMO cannulation. Further randomised studies are still needed to verify its benefit on clinical outcomes.
探讨远端灌注导管(DPC)对静脉-动脉体外膜肺氧合(VA-ECMO)患者血管并发症的预防作用。
纳入我院经股动脉途径行VA-ECMO的患者,根据是否使用DPC分为两组。比较两组的临床指标,包括ECMO运行时间、重症监护病房(ICU)时间、住院时间、ECMO辅助效果、肢体缺血发生率和血管并发症发生率。
本研究共纳入250例患者,包括DPC组(年龄:48[32-62]岁,男性占58.4%,n=125)和非DPC组(年龄:51[36-63]岁,男性占65.6%,n=125)。DPC组发生肢体并发症的可能性低于非DPC组(6.4%对17.6%,P=0.006),主要原因是远端缺血(4.0%对15.2%,P=0.003)和坏死(1.6%对9.6%,P=0.006)。DPC组ECMO持续时间中位数为92.3(75.7-109)小时,非DPC组为71.2(59.4-82.8)小时,差异接近统计学阈值(P=0.054)。两组间ICU时间或住院时间无显著差异。多因素分析显示,调整混杂因素后,植入DPC与肢体并发症呈负相关(比值比:0.265,95%置信区间:0.107-0.657,P=0.004)。
在接受股动脉VA-ECMO插管的患者中,放置远端灌注导管可能与血管并发症和肢体缺血风险降低有关。仍需进一步的随机研究来验证其对临床结局的益处。